Aslan Pharmaceuticals Limited (ASLN) Return on Investment ROI from the fourth quarter of 2023 to fourth quarter of 2022 and for the year 2023, average high and low, overall ranking from Dec 31 2023 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aslan Pharmaceuticals Limited  (NASDAQ: ASLN)


Aslan Pharmaceuticals Limited's ROI from its fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aslan Pharmaceuticals Limited's ROI in the fourth quarter of 2023?
Aslan Pharmaceuticals Limited recorded a cumulative net loss of $-44 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on investment (ROI) of -932.43%.

Within the Healthcare sector Aslan Pharmaceuticals Limited achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the third quarter of 2023 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Investment Change TTM -87.39 % -72.24 % -61.63 % -50.65 % -44.84 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 0 19 0 32
Return On Investment (TTM) - - -249.51 % - -136.64 %
ASLN's Overall Ranking # # # # #
Seq. Investment Change TTM -62.56 % -38.49 % -30.62 % -21.08 % -17.6 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -44 -51 -51 -51 -51

ASLN Company Profile >> Back to ASLN Roi Comparisons >> See Annual ASLN Return On Investment



Return On Investment ASLN's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Aslan Pharmaceuticals Limited's IV. Quarter Investments $ 0 Millions ASLN's Balance sheet
Aslan Pharmaceuticals Limited's IV. Quarter Income $ -44 Millions Quarterly ASLN's Income Statement
ASLN's Income by Division See ASLN's Income by Division


ASLN Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 0 32 64 -2 6
Y / Y Investment Growth - -50.47 % - - -83.85 %
Net Income in Millions -44 -51 -32 -17 -47
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -162.97 % -49.62 % - -748.95 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ASLN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ASLN's Competitors
Subscribers only: Roi for Aslan Pharmaceuticals Limited's Suppliers
Subscribers only: Return On Investment for ASLN's Customers

Other Ratios
ASLN's Roa ASLN's Inventory Turnover Ratio ASLN's Growth Rates ASLN's Dividend Statistics
ASLN's Profitability Ratios ASLN's Asset Turnover Ratio ASLN's Dividend Growth
ASLN's Roe ASLN's Valuation Ratios ASLN's Financial Strength Ratios ASLN's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.